Development of a non-settling gel formulation of 0.5% loteprednol etabonate for anti-inflammatory use as an ophthalmic drop.
about
Impact of the Topical Ophthalmic Corticosteroid Loteprednol Etabonate on Intraocular PressureAn update on the surgical management of pterygium and the role of loteprednol etabonate ointmentTopical Ocular Drug Delivery to the Back of the Eye by Mucus-Penetrating Particles.A retrospective analysis of the postoperative use of loteprednol etabonate gel 0.5% following laser-assisted in situ keratomileusis or photorefractive keratectomy surgeryNeuropathic Corneal Pain: Approaches for Management.A retrospective analysis of the use of loteprednol etabonate ophthalmic suspension 0.5% following canaloplasty.
P2860
Development of a non-settling gel formulation of 0.5% loteprednol etabonate for anti-inflammatory use as an ophthalmic drop.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Development of a non-settling ...... ory use as an ophthalmic drop.
@en
Development of a non-settling ...... ory use as an ophthalmic drop.
@nl
type
label
Development of a non-settling ...... ory use as an ophthalmic drop.
@en
Development of a non-settling ...... ory use as an ophthalmic drop.
@nl
prefLabel
Development of a non-settling ...... ory use as an ophthalmic drop.
@en
Development of a non-settling ...... ory use as an ophthalmic drop.
@nl
P2093
P2860
P356
P1476
Development of a non-settling ...... ory use as an ophthalmic drop.
@en
P2093
Heleen H Decory
Martin J Coffey
Stephen S Lane
P2860
P304
P356
10.2147/OPTH.S40588
P407
P577
2013-02-13T00:00:00Z